Organization · Venture Capital
DAYLI Partners
DAYLI Partners is a venture capital firm based in Seoul, South Korea, specializing in the bio-healthcare sector. They invest in early to pre-IPO life science companies, leveraging a multidisciplinary team and strong industry connections.
Overview
What DAYLI Partners does
What DAYLI Partners is
DAYLI Partners is a venture capital firm based in Seoul, South Korea, specializing in the bio-healthcare sector. They invest in early to pre-IPO life science companies, leveraging a multidisciplinary team and strong industry connections.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2018
- Approximate age
- About 8 years
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find DAYLI Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
DAYLI Partners as a funder
Investment thesis
Healthcare-dedicated VC investing across the biotech/life sciences stack. The team includes MDs, PhDs, and PharmDs, focusing on innovative solutions in bio-healthcare.
Focus narrative
DAYLI Partners invests in industries that drive evolution and innovation, particularly in bio-healthcare and financial governance. The firm is committed to fostering advancements in therapeutics, diagnostics, medical devices, and digital health.
Value beyond capital
DAYLI Partners adds value to its portfolio companies through a combination of strategic guidance, access to a network of industry experts, and support in navigating the complexities of the bio-healthcare landscape. The firm's team of professionals brings a wealth of knowledge and experience to help companies achieve their growth objectives.
Focus and fit
- Stages
- Pre-IPO · Series A · Series B
- Regions
- AsiaNorth America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 80
Portfolio context
DAYLI Partners has a diverse portfolio of over 80 companies, including notable investments such as ALDAVER and DAAN Biotherapeutics, both of which secured Series A funding in 2024.
Common questions
What to know about DAYLI Partners
Upseed classifies DAYLI Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.